Key Takeaways ODD posted Q4 EPS of $0.20 on 23.5% revenue growth to $152.7M, beating estimates.ODD's gross margin fell 220 bps to 70.5%, while EBITDA margin dropped to 8.2%.ODD expects Q1 2026 sales to decline about 30% amid elevated acquisition costs.Oddity Tech Ltd. (ODD) delivered fourth-quarter 2025 results, with both the top and bottom lines surpassing the Zacks Consensus Estimate. Revenues saw year-over-year growth, while the earnings remained flat compared to the previous-year period.Management discl ...

U.S. stocks traded lower midway through trading, with the S&P 500 falling over 1% on Thursday.The Dow traded down 0.31% to 49,329.99 while the NASDAQ dipped 1.90% to 22,711.05. The S&P 500 also fell, dropping, 1.06% to 6,872.77.Check This Out: How To Earn $500 A Month From Goldman Sachs Stock Ahead Of Q4 EarningsLeading and Lagging SectorsEnergy shares gained by 1% on Thursday.In trading on Thursday, information technology stocks fell by 2.6%.Top HeadlineHormel Foods Corp (NYSE:HRL) reported mixed first-qua ...

(Bloomberg) -- A private credit fund jointly managed by Future Standard and KKR & Co. plunged after cutting its dividend more than forecast, as earnings declined amid lower interest rates and losses from troubled investments.FS KKR Capital Corp., a business development company that makes direct loans, tumbled as much as 18% Thursday, the most intraday since 2020. The BDC slashed its quarterly distribution to 48 cents a share from 70 cents, a deeper cut than the 55 cents executives had previously signaled. A ...

Carlyle-backed Quest Global plans India IPO next year, CEO says | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Ajit Prabhu, Chief Executive Officer, Quest Global, speaks at the NASSCOM Technology and Leadership forum in Mumbai, India, February 24, 2026. REUTERS/Francis Mascarenhas [Purchase Licensing Rights, opens new tab]Mumbai, Feb 27 (Reuters) - Singapore-headquartered engineering services firm Quest Global is looking to go pub ...

Most ETFs are built to ride a wave. ProShares Short Bitcoin ETF (NYSEARCA:BITI) is built to profit when that wave crashes. ...

Key Takeaways WBD reported a Q4 loss of 10 cents per share as revenue fell 6% year over year.Warner Bros. Discovery grew streaming subs to 131.6M, up 3.5M sequentially.WBD saw sharp declines in Linear Networks and Studios, pressuring EBITDA and cash flow.Warner Bros. Discovery (WBD) reported a fourth-quarter 2025 loss of 10 cents per share, missing the Zacks Consensus Estimate of earnings of 2 cents. The company had reported a loss of 20 cents per share in the year-ago quarter. Revenues decreased 6% year ov ...

Key Takeaways Palantir posted Q4 revenues of $1.41B, up 70% YoY, with record $4.26B in deal value.PLTR ended Q4 with 954 customers and 138% net dollar retention, signaling expansion.ZETA raised 2026 revenue guidance to $1.75-$1.76B and sees up to $392.1M in EBITDA.Palantir Technologies Inc. (PLTR) and Zeta Global Holdings Corp. (ZETA) are both AI-centric software companies built around transforming massive datasets into actionable intelligence for organizations. Their platforms aggregate, organize, and anal ...

Hertz Global Holdings, Inc. (HTZ) reported $2.03 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of 0.6%. EPS of -$0.63 for the same period compares to -$1.18 a year ago.The reported revenue represents a surprise of +1.07% over the Zacks Consensus Estimate of $2.01 billion. With the consensus EPS estimate being -$0.53, the EPS surprise was -18.11%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expecta ...

Heron Therapeutics (HRTX) reported $40.59 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 0.5%. EPS of -$0.02 for the same period compares to $0.02 a year ago.The reported revenue represents no surprise over the Zacks Consensus Estimate of $0 million. With the consensus EPS estimate being -$0.03, the EPS surprise was +33.33%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine t ...

For the quarter ended December 2025, Collegium Pharmaceutical (COLL) reported revenue of $205.45 million, up 12.9% over the same period last year. EPS came in at $2.04, compared to $1.77 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $208.65 million, representing a surprise of -1.53%. The company delivered an EPS surprise of -6.99%, with the consensus EPS estimate being $2.19.While investors scrutinize revenue and earnings changes year-over-year and how they compare ...